nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexamethasone—NR0B1—germ cell cancer	0.501	1	CbGaD
Dexamethasone—CYP4A11—Cisplatin—germ cell cancer	0.05	0.142	CbGbCtD
Dexamethasone—ABCB11—Vinblastine—germ cell cancer	0.0226	0.0645	CbGbCtD
Dexamethasone—CYP2A6—Ifosfamide—germ cell cancer	0.0219	0.0624	CbGbCtD
Dexamethasone—ABCG2—Dactinomycin—germ cell cancer	0.0172	0.0489	CbGbCtD
Dexamethasone—CYP3A7—Ifosfamide—germ cell cancer	0.015	0.0427	CbGbCtD
Dexamethasone—CYP3A7-CYP3A51P—Ifosfamide—germ cell cancer	0.015	0.0427	CbGbCtD
Dexamethasone—CYP2B6—Ifosfamide—germ cell cancer	0.0143	0.0406	CbGbCtD
Dexamethasone—ABCC2—Vinblastine—germ cell cancer	0.0119	0.0339	CbGbCtD
Dexamethasone—CYP3A5—Ifosfamide—germ cell cancer	0.0112	0.032	CbGbCtD
Dexamethasone—ABCC2—Cisplatin—germ cell cancer	0.0109	0.0311	CbGbCtD
Dexamethasone—CYP2C8—Ifosfamide—germ cell cancer	0.0108	0.0308	CbGbCtD
Dexamethasone—PTGS2—Cisplatin—germ cell cancer	0.0108	0.0307	CbGbCtD
Dexamethasone—ABCC2—Etoposide—germ cell cancer	0.0107	0.0306	CbGbCtD
Dexamethasone—PTGS2—Etoposide—germ cell cancer	0.0106	0.0302	CbGbCtD
Dexamethasone—ABCG2—Cisplatin—germ cell cancer	0.00986	0.0281	CbGbCtD
Dexamethasone—ABCG2—Etoposide—germ cell cancer	0.00969	0.0276	CbGbCtD
Dexamethasone—CYP2C19—Ifosfamide—germ cell cancer	0.00906	0.0258	CbGbCtD
Dexamethasone—SLCO1A2—Methotrexate—germ cell cancer	0.00854	0.0243	CbGbCtD
Dexamethasone—CYP2C9—Ifosfamide—germ cell cancer	0.00753	0.0215	CbGbCtD
Dexamethasone—ABCC2—Methotrexate—germ cell cancer	0.00708	0.0202	CbGbCtD
Dexamethasone—CYP2B6—Cisplatin—germ cell cancer	0.00694	0.0198	CbGbCtD
Dexamethasone—CYP2E1—Etoposide—germ cell cancer	0.00691	0.0197	CbGbCtD
Dexamethasone—ABCG2—Methotrexate—germ cell cancer	0.0064	0.0183	CbGbCtD
Dexamethasone—ABCB1—Dactinomycin—germ cell cancer	0.00619	0.0176	CbGbCtD
Dexamethasone—CYP3A5—Etoposide—germ cell cancer	0.00537	0.0153	CbGbCtD
Dexamethasone—CYP2C8—Etoposide—germ cell cancer	0.00516	0.0147	CbGbCtD
Dexamethasone—CYP3A4—Ifosfamide—germ cell cancer	0.00438	0.0125	CbGbCtD
Dexamethasone—ABCB1—Vinblastine—germ cell cancer	0.00388	0.0111	CbGbCtD
Dexamethasone—CYP2C9—Cisplatin—germ cell cancer	0.00366	0.0104	CbGbCtD
Dexamethasone—CYP2D6—Vinblastine—germ cell cancer	0.00365	0.0104	CbGbCtD
Dexamethasone—ABCB1—Cisplatin—germ cell cancer	0.00356	0.0101	CbGbCtD
Dexamethasone—ABCB1—Etoposide—germ cell cancer	0.00349	0.00996	CbGbCtD
Dexamethasone—CYP3A4—Vinblastine—germ cell cancer	0.00232	0.00662	CbGbCtD
Dexamethasone—ABCB1—Methotrexate—germ cell cancer	0.00231	0.00658	CbGbCtD
Dexamethasone—CYP3A4—Etoposide—germ cell cancer	0.00209	0.00597	CbGbCtD
Dexamethasone—CYP3A43—testis—germ cell cancer	0.000415	0.00793	CbGeAlD
Dexamethasone—NR3C1—urine—germ cell cancer	0.000411	0.00787	CbGeAlD
Dexamethasone—CYP2C9—urine—germ cell cancer	0.000408	0.0078	CbGeAlD
Dexamethasone—ANXA1—trigeminal ganglion—germ cell cancer	0.000396	0.00758	CbGeAlD
Dexamethasone—NR0B1—female gonad—germ cell cancer	0.000387	0.00741	CbGeAlD
Dexamethasone—CYP2E1—urine—germ cell cancer	0.000386	0.00739	CbGeAlD
Dexamethasone—PGR—blood vessel—germ cell cancer	0.000386	0.00739	CbGeAlD
Dexamethasone—ANXA1—embryo—germ cell cancer	0.000383	0.00732	CbGeAlD
Dexamethasone—NR0B1—endocrine gland—germ cell cancer	0.00036	0.00689	CbGeAlD
Dexamethasone—PTGS2—appendage—germ cell cancer	0.000346	0.00663	CbGeAlD
Dexamethasone—NR0B1—testis—germ cell cancer	0.000344	0.00657	CbGeAlD
Dexamethasone—CYP1A1—skin epidermis—germ cell cancer	0.000343	0.00657	CbGeAlD
Dexamethasone—ANXA1—eye—germ cell cancer	0.000341	0.00653	CbGeAlD
Dexamethasone—PLA2G1B—pituitary gland—germ cell cancer	0.000331	0.00634	CbGeAlD
Dexamethasone—ANXA1—telencephalon—germ cell cancer	0.000311	0.00595	CbGeAlD
Dexamethasone—CYP3A4—urine—germ cell cancer	0.000311	0.00595	CbGeAlD
Dexamethasone—CYP4A11—endocrine gland—germ cell cancer	0.00031	0.00593	CbGeAlD
Dexamethasone—CYP2D6—urine—germ cell cancer	0.000306	0.00585	CbGeAlD
Dexamethasone—ANXA1—skin of body—germ cell cancer	0.000297	0.00568	CbGeAlD
Dexamethasone—PLA2G1B—adrenal gland—germ cell cancer	0.000296	0.00566	CbGeAlD
Dexamethasone—ANXA1—decidua—germ cell cancer	0.000295	0.00564	CbGeAlD
Dexamethasone—PTGS2—skin epidermis—germ cell cancer	0.000288	0.00551	CbGeAlD
Dexamethasone—PLA2G1B—female gonad—germ cell cancer	0.000276	0.00528	CbGeAlD
Dexamethasone—ANXA1—gonad—germ cell cancer	0.00026	0.00497	CbGeAlD
Dexamethasone—ANXA1—uterus—germ cell cancer	0.000258	0.00494	CbGeAlD
Dexamethasone—NR0B1—brain—germ cell cancer	0.000258	0.00493	CbGeAlD
Dexamethasone—PLA2G1B—endocrine gland—germ cell cancer	0.000257	0.00491	CbGeAlD
Dexamethasone—NR3C2—trigeminal ganglion—germ cell cancer	0.000257	0.00491	CbGeAlD
Dexamethasone—PLA2G1B—head—germ cell cancer	0.000253	0.00485	CbGeAlD
Dexamethasone—ANXA1—pituitary gland—germ cell cancer	0.000253	0.00485	CbGeAlD
Dexamethasone—CYP11A1—decidua—germ cell cancer	0.000246	0.00471	CbGeAlD
Dexamethasone—PLA2G1B—testis—germ cell cancer	0.000245	0.00468	CbGeAlD
Dexamethasone—ANXA1—medulla oblongata—germ cell cancer	0.000245	0.00468	CbGeAlD
Dexamethasone—CYP17A1—gonad—germ cell cancer	0.000233	0.00445	CbGeAlD
Dexamethasone—NR3C2—brainstem—germ cell cancer	0.000227	0.00434	CbGeAlD
Dexamethasone—ANXA1—adrenal gland—germ cell cancer	0.000226	0.00433	CbGeAlD
Dexamethasone—ANXA1—midbrain—germ cell cancer	0.000223	0.00428	CbGeAlD
Dexamethasone—CYP17A1—medulla oblongata—germ cell cancer	0.000219	0.00419	CbGeAlD
Dexamethasone—NR3C2—retina—germ cell cancer	0.000219	0.00419	CbGeAlD
Dexamethasone—ANXA1—bone marrow—germ cell cancer	0.000219	0.00419	CbGeAlD
Dexamethasone—ANXA1—spinal cord—germ cell cancer	0.000218	0.00417	CbGeAlD
Dexamethasone—CYP11A1—gonad—germ cell cancer	0.000217	0.00414	CbGeAlD
Dexamethasone—ANXA1—female gonad—germ cell cancer	0.000211	0.00404	CbGeAlD
Dexamethasone—PTGS2—endothelium—germ cell cancer	0.000209	0.004	CbGeAlD
Dexamethasone—CYP11A1—medulla oblongata—germ cell cancer	0.000204	0.0039	CbGeAlD
Dexamethasone—CYP17A1—adrenal gland—germ cell cancer	0.000203	0.00388	CbGeAlD
Dexamethasone—NR3C2—telencephalon—germ cell cancer	0.000202	0.00386	CbGeAlD
Dexamethasone—ABCB11—endocrine gland—germ cell cancer	0.0002	0.00382	CbGeAlD
Dexamethasone—ANXA1—endocrine gland—germ cell cancer	0.000196	0.00376	CbGeAlD
Dexamethasone—CYP3A7—endocrine gland—germ cell cancer	0.000195	0.00374	CbGeAlD
Dexamethasone—ANXA1—head—germ cell cancer	0.000194	0.00371	CbGeAlD
Dexamethasone—PTGS2—blood vessel—germ cell cancer	0.000193	0.00369	CbGeAlD
Dexamethasone—ABCB11—testis—germ cell cancer	0.00019	0.00364	CbGeAlD
Dexamethasone—CYP17A1—female gonad—germ cell cancer	0.000189	0.00362	CbGeAlD
Dexamethasone—CYP11A1—adrenal gland—germ cell cancer	0.000189	0.00361	CbGeAlD
Dexamethasone—ANXA1—testis—germ cell cancer	0.000187	0.00358	CbGeAlD
Dexamethasone—PLA2G1B—brain—germ cell cancer	0.000184	0.00351	CbGeAlD
Dexamethasone—PGR—decidua—germ cell cancer	0.000178	0.0034	CbGeAlD
Dexamethasone—CYP11A1—female gonad—germ cell cancer	0.000176	0.00337	CbGeAlD
Dexamethasone—CYP17A1—endocrine gland—germ cell cancer	0.000176	0.00337	CbGeAlD
Dexamethasone—CYP17A1—head—germ cell cancer	0.000174	0.00332	CbGeAlD
Dexamethasone—ANXA1—cerebellum—germ cell cancer	0.000173	0.00331	CbGeAlD
Dexamethasone—CYP1B1—eye—germ cell cancer	0.000173	0.00331	CbGeAlD
Dexamethasone—SLCO1A2—telencephalon—germ cell cancer	0.000173	0.0033	CbGeAlD
Dexamethasone—CYP17A1—testis—germ cell cancer	0.000168	0.00321	CbGeAlD
Dexamethasone—SLCO1A2—Transport of vitamins, nucleosides, and related molecules—AVP—germ cell cancer	0.000167	0.00506	CbGpPWpGaD
Dexamethasone—CYP4A11—NRF2 pathway—SLC2A3—germ cell cancer	0.000167	0.00505	CbGpPWpGaD
Dexamethasone—NR3C2—uterus—germ cell cancer	0.000167	0.0032	CbGeAlD
Dexamethasone—NR3C2—pituitary gland—germ cell cancer	0.000164	0.00314	CbGeAlD
Dexamethasone—CYP11A1—endocrine gland—germ cell cancer	0.000164	0.00313	CbGeAlD
Dexamethasone—CYP11A1—head—germ cell cancer	0.000162	0.00309	CbGeAlD
Dexamethasone—Cardiac arrest—Etoposide—germ cell cancer	0.000161	0.00258	CcSEcCtD
Dexamethasone—Vertigo—Vinblastine—germ cell cancer	0.000161	0.00257	CcSEcCtD
Dexamethasone—Conjunctivitis—Ifosfamide—germ cell cancer	0.000161	0.00257	CcSEcCtD
Dexamethasone—Extravasation—Methotrexate—germ cell cancer	0.00016	0.00256	CcSEcCtD
Dexamethasone—NR3C1—neck—germ cell cancer	0.000159	0.00305	CbGeAlD
Dexamethasone—CYP2D6—Metapathway biotransformation—NAT9—germ cell cancer	0.000159	0.0048	CbGpPWpGaD
Dexamethasone—NR3C2—medulla oblongata—germ cell cancer	0.000158	0.00303	CbGeAlD
Dexamethasone—CYP1B1—telencephalon—germ cell cancer	0.000158	0.00302	CbGeAlD
Dexamethasone—CYP2C9—Metapathway biotransformation—NAT9—germ cell cancer	0.000158	0.00476	CbGpPWpGaD
Dexamethasone—CYP11A1—testis—germ cell cancer	0.000156	0.00299	CbGeAlD
Dexamethasone—Sweating increased—Cisplatin—germ cell cancer	0.000156	0.00249	CcSEcCtD
Dexamethasone—PGR—uterus—germ cell cancer	0.000155	0.00297	CbGeAlD
Dexamethasone—Convulsion—Vinblastine—germ cell cancer	0.000155	0.00248	CcSEcCtD
Dexamethasone—Hypertension—Vinblastine—germ cell cancer	0.000154	0.00247	CcSEcCtD
Dexamethasone—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—OXT—germ cell cancer	0.000154	0.00466	CbGpPWpGaD
Dexamethasone—Alopecia—Bleomycin—germ cell cancer	0.000153	0.00246	CcSEcCtD
Dexamethasone—PGR—pituitary gland—germ cell cancer	0.000153	0.00292	CbGeAlD
Dexamethasone—Herpes simplex—Methotrexate—germ cell cancer	0.000152	0.00243	CcSEcCtD
Dexamethasone—Erythema—Bleomycin—germ cell cancer	0.000151	0.00242	CcSEcCtD
Dexamethasone—Bradycardia—Ifosfamide—germ cell cancer	0.000151	0.00242	CcSEcCtD
Dexamethasone—Discomfort—Vinblastine—germ cell cancer	0.000151	0.00241	CcSEcCtD
Dexamethasone—CYP1B1—skin of body—germ cell cancer	0.00015	0.00288	CbGeAlD
Dexamethasone—CYP2E1—Vitamin A and Carotenoid Metabolism—CRABP1—germ cell cancer	0.00015	0.00454	CbGpPWpGaD
Dexamethasone—ABCG2—trigeminal ganglion—germ cell cancer	0.000149	0.00286	CbGeAlD
Dexamethasone—CYP1B1—decidua—germ cell cancer	0.000149	0.00286	CbGeAlD
Dexamethasone—Haemoglobin—Ifosfamide—germ cell cancer	0.000149	0.00239	CcSEcCtD
Dexamethasone—Haemorrhage—Ifosfamide—germ cell cancer	0.000148	0.00238	CcSEcCtD
Dexamethasone—Ulcer—Methotrexate—germ cell cancer	0.000148	0.00237	CcSEcCtD
Dexamethasone—Hallucination—Ifosfamide—germ cell cancer	0.000148	0.00236	CcSEcCtD
Dexamethasone—NR3C2—adrenal gland—germ cell cancer	0.000147	0.0028	CbGeAlD
Dexamethasone—NR3C2—midbrain—germ cell cancer	0.000145	0.00277	CbGeAlD
Dexamethasone—Vasculitis—Methotrexate—germ cell cancer	0.000143	0.00229	CcSEcCtD
Dexamethasone—Alopecia—Dactinomycin—germ cell cancer	0.000143	0.00229	CcSEcCtD
Dexamethasone—Thrombocytopenia—Vinblastine—germ cell cancer	0.000143	0.00229	CcSEcCtD
Dexamethasone—Visual impairment—Ifosfamide—germ cell cancer	0.000143	0.00229	CcSEcCtD
Dexamethasone—Sweating increased—Etoposide—germ cell cancer	0.000143	0.00228	CcSEcCtD
Dexamethasone—NR3C1—Endoderm Differentiation—SOX2—germ cell cancer	0.000142	0.0043	CbGpPWpGaD
Dexamethasone—NR3C2—spinal cord—germ cell cancer	0.000141	0.0027	CbGeAlD
Dexamethasone—Erythema—Dactinomycin—germ cell cancer	0.000141	0.00226	CcSEcCtD
Dexamethasone—CYP19A1—gonad—germ cell cancer	0.000141	0.00269	CbGeAlD
Dexamethasone—Acute coronary syndrome—Cisplatin—germ cell cancer	0.00014	0.00225	CcSEcCtD
Dexamethasone—ANXA1—brain—germ cell cancer	0.00014	0.00269	CbGeAlD
Dexamethasone—Ill-defined disorder—Bleomycin—germ cell cancer	0.00014	0.00224	CcSEcCtD
Dexamethasone—CYP19A1—uterus—germ cell cancer	0.00014	0.00267	CbGeAlD
Dexamethasone—Neuropathy peripheral—Cisplatin—germ cell cancer	0.00014	0.00224	CcSEcCtD
Dexamethasone—Myocardial infarction—Cisplatin—germ cell cancer	0.00014	0.00224	CcSEcCtD
Dexamethasone—Anorexia—Vinblastine—germ cell cancer	0.000139	0.00223	CcSEcCtD
Dexamethasone—Eye disorder—Ifosfamide—germ cell cancer	0.000139	0.00222	CcSEcCtD
Dexamethasone—Conjunctivitis—Cisplatin—germ cell cancer	0.000139	0.00222	CcSEcCtD
Dexamethasone—NR3C1—trigeminal ganglion—germ cell cancer	0.000138	0.00263	CbGeAlD
Dexamethasone—NR3C1—SIDS Susceptibility Pathways—NANOG—germ cell cancer	0.000137	0.00414	CbGpPWpGaD
Dexamethasone—NR3C2—female gonad—germ cell cancer	0.000137	0.00261	CbGeAlD
Dexamethasone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—AVP—germ cell cancer	0.000136	0.00412	CbGpPWpGaD
Dexamethasone—Malaise—Bleomycin—germ cell cancer	0.000136	0.00218	CcSEcCtD
Dexamethasone—PGR—adrenal gland—germ cell cancer	0.000136	0.00261	CbGeAlD
Dexamethasone—SLCO1A2—medulla oblongata—germ cell cancer	0.000136	0.0026	CbGeAlD
Dexamethasone—ANXA1—lymph node—germ cell cancer	0.000136	0.0026	CbGeAlD
Dexamethasone—Angiopathy—Ifosfamide—germ cell cancer	0.000135	0.00216	CcSEcCtD
Dexamethasone—Skin exfoliation—Methotrexate—germ cell cancer	0.000133	0.00214	CcSEcCtD
Dexamethasone—NR3C1—embryo—germ cell cancer	0.000133	0.00254	CbGeAlD
Dexamethasone—Arrhythmia—Ifosfamide—germ cell cancer	0.000133	0.00212	CcSEcCtD
Dexamethasone—NR3C1—SIDS Susceptibility Pathways—POU5F1—germ cell cancer	0.000132	0.00399	CbGpPWpGaD
Dexamethasone—CYP1B1—gonad—germ cell cancer	0.000132	0.00252	CbGeAlD
Dexamethasone—Paraesthesia—Vinblastine—germ cell cancer	0.000131	0.0021	CcSEcCtD
Dexamethasone—Alopecia—Ifosfamide—germ cell cancer	0.000131	0.0021	CcSEcCtD
Dexamethasone—Ill-defined disorder—Dactinomycin—germ cell cancer	0.000131	0.00209	CcSEcCtD
Dexamethasone—CYP1B1—uterus—germ cell cancer	0.000131	0.0025	CbGeAlD
Dexamethasone—Bradycardia—Cisplatin—germ cell cancer	0.00013	0.00208	CcSEcCtD
Dexamethasone—Erythema—Ifosfamide—germ cell cancer	0.000129	0.00207	CcSEcCtD
Dexamethasone—Acute coronary syndrome—Etoposide—germ cell cancer	0.000129	0.00206	CcSEcCtD
Dexamethasone—Myalgia—Bleomycin—germ cell cancer	0.000129	0.00206	CcSEcCtD
Dexamethasone—CYP1B1—pituitary gland—germ cell cancer	0.000128	0.00245	CbGeAlD
Dexamethasone—Myocardial infarction—Etoposide—germ cell cancer	0.000128	0.00205	CcSEcCtD
Dexamethasone—Neuropathy peripheral—Etoposide—germ cell cancer	0.000128	0.00205	CcSEcCtD
Dexamethasone—Discomfort—Bleomycin—germ cell cancer	0.000127	0.00204	CcSEcCtD
Dexamethasone—NR3C2—endocrine gland—germ cell cancer	0.000127	0.00243	CbGeAlD
Dexamethasone—Malaise—Dactinomycin—germ cell cancer	0.000127	0.00203	CcSEcCtD
Dexamethasone—PGR—female gonad—germ cell cancer	0.000127	0.00243	CbGeAlD
Dexamethasone—Decreased appetite—Vinblastine—germ cell cancer	0.000127	0.00203	CcSEcCtD
Dexamethasone—Ecchymosis—Methotrexate—germ cell cancer	0.000126	0.00202	CcSEcCtD
Dexamethasone—CYP17A1—brain—germ cell cancer	0.000126	0.00241	CbGeAlD
Dexamethasone—NR0B1—Validated nuclear estrogen receptor alpha network—MYC—germ cell cancer	0.000126	0.0038	CbGpPWpGaD
Dexamethasone—NR3C2—head—germ cell cancer	0.000125	0.0024	CbGeAlD
Dexamethasone—Pain—Vinblastine—germ cell cancer	0.000125	0.002	CcSEcCtD
Dexamethasone—Pulmonary oedema—Methotrexate—germ cell cancer	0.000124	0.00199	CcSEcCtD
Dexamethasone—SLCO1A2—midbrain—germ cell cancer	0.000124	0.00237	CbGeAlD
Dexamethasone—Anaphylactic shock—Bleomycin—germ cell cancer	0.000123	0.00197	CcSEcCtD
Dexamethasone—Oedema—Bleomycin—germ cell cancer	0.000123	0.00197	CcSEcCtD
Dexamethasone—Visual impairment—Cisplatin—germ cell cancer	0.000123	0.00197	CcSEcCtD
Dexamethasone—CYP19A1—adrenal gland—germ cell cancer	0.000123	0.00235	CbGeAlD
Dexamethasone—Infection—Bleomycin—germ cell cancer	0.000123	0.00196	CcSEcCtD
Dexamethasone—NR3C1—brainstem—germ cell cancer	0.000122	0.00233	CbGeAlD
Dexamethasone—CYP17A1—lymph node—germ cell cancer	0.000122	0.00233	CbGeAlD
Dexamethasone—NR3C2—testis—germ cell cancer	0.000121	0.00232	CbGeAlD
Dexamethasone—SLCO1A2—spinal cord—germ cell cancer	0.000121	0.00232	CbGeAlD
Dexamethasone—Thrombocytopenia—Bleomycin—germ cell cancer	0.000121	0.00193	CcSEcCtD
Dexamethasone—Feeling abnormal—Vinblastine—germ cell cancer	0.00012	0.00193	CcSEcCtD
Dexamethasone—Myalgia—Dactinomycin—germ cell cancer	0.00012	0.00192	CcSEcCtD
Dexamethasone—Ill-defined disorder—Ifosfamide—germ cell cancer	0.00012	0.00192	CcSEcCtD
Dexamethasone—Eye disorder—Cisplatin—germ cell cancer	0.00012	0.00191	CcSEcCtD
Dexamethasone—CYP2A6—cerebellum—germ cell cancer	0.000119	0.00229	CbGeAlD
Dexamethasone—Gastrointestinal pain—Vinblastine—germ cell cancer	0.000119	0.00191	CcSEcCtD
Dexamethasone—ABCB1—blood vessel—germ cell cancer	0.000119	0.00228	CbGeAlD
Dexamethasone—PTGS2—trigeminal ganglion—germ cell cancer	0.000119	0.00228	CbGeAlD
Dexamethasone—NR3C1—eye—germ cell cancer	0.000119	0.00227	CbGeAlD
Dexamethasone—Discomfort—Dactinomycin—germ cell cancer	0.000119	0.0019	CcSEcCtD
Dexamethasone—PGR—endocrine gland—germ cell cancer	0.000118	0.00226	CbGeAlD
Dexamethasone—ANXA1—G alpha (q) signalling events—AVP—germ cell cancer	0.000118	0.00357	CbGpPWpGaD
Dexamethasone—Angioedema—Ifosfamide—germ cell cancer	0.000118	0.00189	CcSEcCtD
Dexamethasone—CYP4A11—PPAR Alpha Pathway—MYC—germ cell cancer	0.000118	0.00356	CbGpPWpGaD
Dexamethasone—Anorexia—Bleomycin—germ cell cancer	0.000118	0.00188	CcSEcCtD
Dexamethasone—ABCG2—telencephalon—germ cell cancer	0.000117	0.00225	CbGeAlD
Dexamethasone—Thrombophlebitis—Methotrexate—germ cell cancer	0.000117	0.00188	CcSEcCtD
Dexamethasone—CYP11A1—brain—germ cell cancer	0.000117	0.00224	CbGeAlD
Dexamethasone—ABCC2—adrenal gland—germ cell cancer	0.000117	0.00224	CbGeAlD
Dexamethasone—PGR—head—germ cell cancer	0.000117	0.00223	CbGeAlD
Dexamethasone—Diabetes mellitus—Methotrexate—germ cell cancer	0.000117	0.00187	CcSEcCtD
Dexamethasone—ANXA1—Peptide ligand-binding receptors—AVP—germ cell cancer	0.000117	0.00352	CbGpPWpGaD
Dexamethasone—Malaise—Ifosfamide—germ cell cancer	0.000116	0.00186	CcSEcCtD
Dexamethasone—Vertigo—Ifosfamide—germ cell cancer	0.000116	0.00186	CcSEcCtD
Dexamethasone—PGR—Generic Transcription Pathway—NR0B1—germ cell cancer	0.000116	0.00349	CbGpPWpGaD
Dexamethasone—Abdominal pain—Vinblastine—germ cell cancer	0.000115	0.00185	CcSEcCtD
Dexamethasone—Hypotension—Bleomycin—germ cell cancer	0.000115	0.00185	CcSEcCtD
Dexamethasone—PTGS2—embryo—germ cell cancer	0.000115	0.0022	CbGeAlD
Dexamethasone—Oedema—Dactinomycin—germ cell cancer	0.000115	0.00184	CcSEcCtD
Dexamethasone—CYP1B1—adrenal gland—germ cell cancer	0.000115	0.00219	CbGeAlD
Dexamethasone—CYP19A1—female gonad—germ cell cancer	0.000114	0.00219	CbGeAlD
Dexamethasone—Infection—Dactinomycin—germ cell cancer	0.000114	0.00183	CcSEcCtD
Dexamethasone—Arrhythmia—Cisplatin—germ cell cancer	0.000114	0.00183	CcSEcCtD
Dexamethasone—ANXA1—Class A/1 (Rhodopsin-like receptors)—OXT—germ cell cancer	0.000114	0.00345	CbGpPWpGaD
Dexamethasone—CYP4A11—Fatty acid, triacylglycerol, and ketone body metabolism—CRABP1—germ cell cancer	0.000113	0.00343	CbGpPWpGaD
Dexamethasone—CYP11A1—lymph node—germ cell cancer	0.000113	0.00216	CbGeAlD
Dexamethasone—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—SLC2A3—germ cell cancer	0.000113	0.00342	CbGpPWpGaD
Dexamethasone—Alopecia—Cisplatin—germ cell cancer	0.000113	0.00181	CcSEcCtD
Dexamethasone—PGR—testis—germ cell cancer	0.000113	0.00216	CbGeAlD
Dexamethasone—ABCC2—NRF2 pathway—SLC2A3—germ cell cancer	0.000113	0.0034	CbGpPWpGaD
Dexamethasone—Thrombocytopenia—Dactinomycin—germ cell cancer	0.000113	0.0018	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.000112	0.0018	CcSEcCtD
Dexamethasone—NR3C2—cerebellum—germ cell cancer	0.000112	0.00214	CbGeAlD
Dexamethasone—Convulsion—Ifosfamide—germ cell cancer	0.000112	0.00179	CcSEcCtD
Dexamethasone—Hypertension—Ifosfamide—germ cell cancer	0.000112	0.00179	CcSEcCtD
Dexamethasone—Erythema—Cisplatin—germ cell cancer	0.000111	0.00178	CcSEcCtD
Dexamethasone—ABCG2—decidua—germ cell cancer	0.000111	0.00213	CbGeAlD
Dexamethasone—Paraesthesia—Bleomycin—germ cell cancer	0.000111	0.00177	CcSEcCtD
Dexamethasone—Myalgia—Ifosfamide—germ cell cancer	0.00011	0.00176	CcSEcCtD
Dexamethasone—Anorexia—Dactinomycin—germ cell cancer	0.00011	0.00176	CcSEcCtD
Dexamethasone—Eye disorder—Etoposide—germ cell cancer	0.00011	0.00175	CcSEcCtD
Dexamethasone—SLCO1A2—endocrine gland—germ cell cancer	0.000109	0.00208	CbGeAlD
Dexamethasone—Discomfort—Ifosfamide—germ cell cancer	0.000109	0.00174	CcSEcCtD
Dexamethasone—NR3C1—telencephalon—germ cell cancer	0.000108	0.00207	CbGeAlD
Dexamethasone—SLCO1A2—head—germ cell cancer	0.000108	0.00206	CbGeAlD
Dexamethasone—NOS2—Signaling mediated by p38-alpha and p38-beta—TP53—germ cell cancer	0.000107	0.00324	CbGpPWpGaD
Dexamethasone—Decreased appetite—Bleomycin—germ cell cancer	0.000107	0.00172	CcSEcCtD
Dexamethasone—Visual disturbance—Methotrexate—germ cell cancer	0.000107	0.00171	CcSEcCtD
Dexamethasone—CYP1B1—female gonad—germ cell cancer	0.000107	0.00204	CbGeAlD
Dexamethasone—CYP19A1—endocrine gland—germ cell cancer	0.000106	0.00203	CbGeAlD
Dexamethasone—CYP1A1—skin of body—germ cell cancer	0.000106	0.00203	CbGeAlD
Dexamethasone—Angiopathy—Etoposide—germ cell cancer	0.000106	0.0017	CcSEcCtD
Dexamethasone—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—germ cell cancer	0.000106	0.00319	CbGpPWpGaD
Dexamethasone—Pain—Bleomycin—germ cell cancer	0.000105	0.00169	CcSEcCtD
Dexamethasone—Anaphylactic shock—Ifosfamide—germ cell cancer	0.000105	0.00169	CcSEcCtD
Dexamethasone—Oedema—Ifosfamide—germ cell cancer	0.000105	0.00169	CcSEcCtD
Dexamethasone—CYP19A1—head—germ cell cancer	0.000105	0.00201	CbGeAlD
Dexamethasone—Anaphylactoid reaction—Methotrexate—germ cell cancer	0.000105	0.00168	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.000105	0.00168	CcSEcCtD
Dexamethasone—Asthenia—Vinblastine—germ cell cancer	0.000105	0.00168	CcSEcCtD
Dexamethasone—Infection—Ifosfamide—germ cell cancer	0.000105	0.00168	CcSEcCtD
Dexamethasone—PGR—cerebellum—germ cell cancer	0.000104	0.00199	CbGeAlD
Dexamethasone—CYP3A4—Metapathway biotransformation—NAT9—germ cell cancer	0.000104	0.00314	CbGpPWpGaD
Dexamethasone—SLCO1A2—testis—germ cell cancer	0.000104	0.00199	CbGeAlD
Dexamethasone—NR0B1—Gene Expression—DNMT3L—germ cell cancer	0.000104	0.00314	CbGpPWpGaD
Dexamethasone—Alopecia—Etoposide—germ cell cancer	0.000104	0.00166	CcSEcCtD
Dexamethasone—Lethargy—Methotrexate—germ cell cancer	0.000104	0.00166	CcSEcCtD
Dexamethasone—Nervous system disorder—Ifosfamide—germ cell cancer	0.000103	0.00166	CcSEcCtD
Dexamethasone—CYP2B6—skin of body—germ cell cancer	0.000103	0.00198	CbGeAlD
Dexamethasone—Ill-defined disorder—Cisplatin—germ cell cancer	0.000103	0.00165	CcSEcCtD
Dexamethasone—Thrombocytopenia—Ifosfamide—germ cell cancer	0.000103	0.00165	CcSEcCtD
Dexamethasone—NR3C1—skin of body—germ cell cancer	0.000103	0.00197	CbGeAlD
Dexamethasone—NR3C1—decidua—germ cell cancer	0.000102	0.00196	CbGeAlD
Dexamethasone—Hyperhidrosis—Ifosfamide—germ cell cancer	0.000102	0.00163	CcSEcCtD
Dexamethasone—Feeling abnormal—Bleomycin—germ cell cancer	0.000102	0.00163	CcSEcCtD
Dexamethasone—CYP2E1—telencephalon—germ cell cancer	0.000102	0.00194	CbGeAlD
Dexamethasone—ABCC2—endocrine gland—germ cell cancer	0.000102	0.00194	CbGeAlD
Dexamethasone—Osteoarthritis—Methotrexate—germ cell cancer	0.000101	0.00162	CcSEcCtD
Dexamethasone—CYP19A1—testis—germ cell cancer	0.000101	0.00194	CbGeAlD
Dexamethasone—Anorexia—Ifosfamide—germ cell cancer	0.0001	0.00161	CcSEcCtD
Dexamethasone—Malaise—Cisplatin—germ cell cancer	0.0001	0.00161	CcSEcCtD
Dexamethasone—Decreased appetite—Dactinomycin—germ cell cancer	0.0001	0.0016	CcSEcCtD
Dexamethasone—Diarrhoea—Vinblastine—germ cell cancer	9.99e-05	0.0016	CcSEcCtD
Dexamethasone—CYP1B1—endocrine gland—germ cell cancer	9.94e-05	0.0019	CbGeAlD
Dexamethasone—NR3C1—Circadian Clock—AVP—germ cell cancer	9.93e-05	0.003	CbGpPWpGaD
Dexamethasone—Fatigue—Dactinomycin—germ cell cancer	9.92e-05	0.00159	CcSEcCtD
Dexamethasone—Hypotension—Ifosfamide—germ cell cancer	9.85e-05	0.00158	CcSEcCtD
Dexamethasone—Pain—Dactinomycin—germ cell cancer	9.84e-05	0.00157	CcSEcCtD
Dexamethasone—CYP2C8—pituitary gland—germ cell cancer	9.83e-05	0.00188	CbGeAlD
Dexamethasone—CYP1B1—head—germ cell cancer	9.81e-05	0.00188	CbGeAlD
Dexamethasone—Urticaria—Bleomycin—germ cell cancer	9.8e-05	0.00157	CcSEcCtD
Dexamethasone—Body temperature increased—Bleomycin—germ cell cancer	9.75e-05	0.00156	CcSEcCtD
Dexamethasone—ABCG2—uterus—germ cell cancer	9.73e-05	0.00186	CbGeAlD
Dexamethasone—CYP2A6—brain—germ cell cancer	9.7e-05	0.00186	CbGeAlD
Dexamethasone—Irritability—Methotrexate—germ cell cancer	9.68e-05	0.00155	CcSEcCtD
Dexamethasone—ABCC2—testis—germ cell cancer	9.68e-05	0.00185	CbGeAlD
Dexamethasone—Dizziness—Vinblastine—germ cell cancer	9.66e-05	0.00155	CcSEcCtD
Dexamethasone—Convulsion—Cisplatin—germ cell cancer	9.65e-05	0.00154	CcSEcCtD
Dexamethasone—NR0B1—Gene Expression—RARS—germ cell cancer	9.64e-05	0.00291	CbGpPWpGaD
Dexamethasone—Mood swings—Methotrexate—germ cell cancer	9.61e-05	0.00154	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	9.6e-05	0.00154	CcSEcCtD
Dexamethasone—SLCO1A2—cerebellum—germ cell cancer	9.6e-05	0.00184	CbGeAlD
Dexamethasone—ABCG2—pituitary gland—germ cell cancer	9.56e-05	0.00183	CbGeAlD
Dexamethasone—PGR—Signaling by ERBB4—FGF4—germ cell cancer	9.49e-05	0.00287	CbGpPWpGaD
Dexamethasone—CYP1B1—testis—germ cell cancer	9.48e-05	0.00181	CbGeAlD
Dexamethasone—Myalgia—Cisplatin—germ cell cancer	9.48e-05	0.00152	CcSEcCtD
Dexamethasone—Feeling abnormal—Dactinomycin—germ cell cancer	9.48e-05	0.00152	CcSEcCtD
Dexamethasone—Paraesthesia—Ifosfamide—germ cell cancer	9.47e-05	0.00152	CcSEcCtD
Dexamethasone—Ill-defined disorder—Etoposide—germ cell cancer	9.46e-05	0.00152	CcSEcCtD
Dexamethasone—Anxiety—Cisplatin—germ cell cancer	9.45e-05	0.00151	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Dactinomycin—germ cell cancer	9.41e-05	0.00151	CcSEcCtD
Dexamethasone—Discomfort—Cisplatin—germ cell cancer	9.37e-05	0.0015	CcSEcCtD
Dexamethasone—PTGS2—telencephalon—germ cell cancer	9.36e-05	0.00179	CbGeAlD
Dexamethasone—Vomiting—Vinblastine—germ cell cancer	9.29e-05	0.00149	CcSEcCtD
Dexamethasone—CYP1A1—uterus—germ cell cancer	9.24e-05	0.00177	CbGeAlD
Dexamethasone—ABCG2—medulla oblongata—germ cell cancer	9.22e-05	0.00176	CbGeAlD
Dexamethasone—Malaise—Etoposide—germ cell cancer	9.2e-05	0.00147	CcSEcCtD
Dexamethasone—Vertigo—Etoposide—germ cell cancer	9.17e-05	0.00147	CcSEcCtD
Dexamethasone—Decreased appetite—Ifosfamide—germ cell cancer	9.16e-05	0.00147	CcSEcCtD
Dexamethasone—Headache—Vinblastine—germ cell cancer	9.15e-05	0.00146	CcSEcCtD
Dexamethasone—NR3C2—Gene Expression—NR0B1—germ cell cancer	9.13e-05	0.00276	CbGpPWpGaD
Dexamethasone—Gastrointestinal disorder—Ifosfamide—germ cell cancer	9.1e-05	0.00146	CcSEcCtD
Dexamethasone—NR3C2—brain—germ cell cancer	9.09e-05	0.00174	CbGeAlD
Dexamethasone—Body temperature increased—Dactinomycin—germ cell cancer	9.09e-05	0.00146	CcSEcCtD
Dexamethasone—Abdominal pain—Dactinomycin—germ cell cancer	9.09e-05	0.00146	CcSEcCtD
Dexamethasone—Fatigue—Ifosfamide—germ cell cancer	9.09e-05	0.00146	CcSEcCtD
Dexamethasone—Oedema—Cisplatin—germ cell cancer	9.09e-05	0.00145	CcSEcCtD
Dexamethasone—Anaphylactic shock—Cisplatin—germ cell cancer	9.09e-05	0.00145	CcSEcCtD
Dexamethasone—CYP2D6—brainstem—germ cell cancer	9.07e-05	0.00173	CbGeAlD
Dexamethasone—CYP2B6—gonad—germ cell cancer	9.04e-05	0.00173	CbGeAlD
Dexamethasone—Infection—Cisplatin—germ cell cancer	9.03e-05	0.00145	CcSEcCtD
Dexamethasone—NR3C1—gonad—germ cell cancer	9.02e-05	0.00173	CbGeAlD
Dexamethasone—Pain—Ifosfamide—germ cell cancer	9.01e-05	0.00144	CcSEcCtD
Dexamethasone—Loss of consciousness—Etoposide—germ cell cancer	8.97e-05	0.00144	CcSEcCtD
Dexamethasone—NR3C1—uterus—germ cell cancer	8.96e-05	0.00171	CbGeAlD
Dexamethasone—PTGS2—skin of body—germ cell cancer	8.93e-05	0.00171	CbGeAlD
Dexamethasone—Nervous system disorder—Cisplatin—germ cell cancer	8.91e-05	0.00143	CcSEcCtD
Dexamethasone—CYP2A6—NRF2 pathway—SLC2A3—germ cell cancer	8.9e-05	0.00269	CbGpPWpGaD
Dexamethasone—Thrombocytopenia—Cisplatin—germ cell cancer	8.9e-05	0.00142	CcSEcCtD
Dexamethasone—Tachycardia—Cisplatin—germ cell cancer	8.87e-05	0.00142	CcSEcCtD
Dexamethasone—Asthenia—Bleomycin—germ cell cancer	8.85e-05	0.00142	CcSEcCtD
Dexamethasone—Convulsion—Etoposide—germ cell cancer	8.84e-05	0.00142	CcSEcCtD
Dexamethasone—Hypertension—Etoposide—germ cell cancer	8.81e-05	0.00141	CcSEcCtD
Dexamethasone—NR3C1—pituitary gland—germ cell cancer	8.8e-05	0.00168	CbGeAlD
Dexamethasone—NR3C2—lymph node—germ cell cancer	8.79e-05	0.00168	CbGeAlD
Dexamethasone—Hyperhidrosis—Cisplatin—germ cell cancer	8.79e-05	0.00141	CcSEcCtD
Dexamethasone—CYP1B1—cerebellum—germ cell cancer	8.76e-05	0.00168	CbGeAlD
Dexamethasone—Pruritus—Bleomycin—germ cell cancer	8.73e-05	0.0014	CcSEcCtD
Dexamethasone—CYP2C19—endocrine gland—germ cell cancer	8.72e-05	0.00167	CbGeAlD
Dexamethasone—Feeling abnormal—Ifosfamide—germ cell cancer	8.69e-05	0.00139	CcSEcCtD
Dexamethasone—ANXA1—GPCR ligand binding—OXT—germ cell cancer	8.69e-05	0.00263	CbGpPWpGaD
Dexamethasone—Nausea—Vinblastine—germ cell cancer	8.67e-05	0.00139	CcSEcCtD
Dexamethasone—Anorexia—Cisplatin—germ cell cancer	8.66e-05	0.00139	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Ifosfamide—germ cell cancer	8.62e-05	0.00138	CcSEcCtD
Dexamethasone—Discomfort—Etoposide—germ cell cancer	8.58e-05	0.00137	CcSEcCtD
Dexamethasone—PLA2G1B—Fc-epsilon receptor I signaling in mast cells—HRAS—germ cell cancer	8.56e-05	0.00259	CbGpPWpGaD
Dexamethasone—ABCG2—adrenal gland—germ cell cancer	8.54e-05	0.00163	CbGeAlD
Dexamethasone—NR3C1—medulla oblongata—germ cell cancer	8.49e-05	0.00162	CbGeAlD
Dexamethasone—Hypotension—Cisplatin—germ cell cancer	8.49e-05	0.00136	CcSEcCtD
Dexamethasone—PGR—brain—germ cell cancer	8.45e-05	0.00162	CbGeAlD
Dexamethasone—NOS2—Hemostasis—CD9—germ cell cancer	8.45e-05	0.00255	CbGpPWpGaD
Dexamethasone—ABCG2—midbrain—germ cell cancer	8.43e-05	0.00161	CbGeAlD
Dexamethasone—NOS2—Circadian rythm related genes—AVP—germ cell cancer	8.4e-05	0.00254	CbGpPWpGaD
Dexamethasone—Urticaria—Ifosfamide—germ cell cancer	8.37e-05	0.00134	CcSEcCtD
Dexamethasone—Abdominal pain—Ifosfamide—germ cell cancer	8.33e-05	0.00133	CcSEcCtD
Dexamethasone—Body temperature increased—Ifosfamide—germ cell cancer	8.33e-05	0.00133	CcSEcCtD
Dexamethasone—Anaphylactic shock—Etoposide—germ cell cancer	8.33e-05	0.00133	CcSEcCtD
Dexamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	8.28e-05	0.0025	CbGpPWpGaD
Dexamethasone—Musculoskeletal discomfort—Cisplatin—germ cell cancer	8.28e-05	0.00133	CcSEcCtD
Dexamethasone—Infection—Etoposide—germ cell cancer	8.27e-05	0.00132	CcSEcCtD
Dexamethasone—ABCG2—bone marrow—germ cell cancer	8.26e-05	0.00158	CbGeAlD
Dexamethasone—Asthenia—Dactinomycin—germ cell cancer	8.25e-05	0.00132	CcSEcCtD
Dexamethasone—ABCG2—spinal cord—germ cell cancer	8.22e-05	0.00157	CbGeAlD
Dexamethasone—PGR—lymph node—germ cell cancer	8.17e-05	0.00156	CbGeAlD
Dexamethasone—Paraesthesia—Cisplatin—germ cell cancer	8.16e-05	0.00131	CcSEcCtD
Dexamethasone—Thrombocytopenia—Etoposide—germ cell cancer	8.15e-05	0.00131	CcSEcCtD
Dexamethasone—Tachycardia—Etoposide—germ cell cancer	8.13e-05	0.0013	CcSEcCtD
Dexamethasone—Hyperhidrosis—Etoposide—germ cell cancer	8.05e-05	0.00129	CcSEcCtD
Dexamethasone—CYP2D6—telencephalon—germ cell cancer	8.05e-05	0.00154	CbGeAlD
Dexamethasone—CYP2E1—medulla oblongata—germ cell cancer	7.98e-05	0.00153	CbGeAlD
Dexamethasone—ABCG2—female gonad—germ cell cancer	7.96e-05	0.00152	CbGeAlD
Dexamethasone—Anorexia—Etoposide—germ cell cancer	7.94e-05	0.00127	CcSEcCtD
Dexamethasone—NR3C2—Gene Expression—DNMT3L—germ cell cancer	7.92e-05	0.00239	CbGpPWpGaD
Dexamethasone—Decreased appetite—Cisplatin—germ cell cancer	7.9e-05	0.00126	CcSEcCtD
Dexamethasone—CYP2B6—adrenal gland—germ cell cancer	7.88e-05	0.00151	CbGeAlD
Dexamethasone—Diarrhoea—Dactinomycin—germ cell cancer	7.87e-05	0.00126	CcSEcCtD
Dexamethasone—NR3C1—adrenal gland—germ cell cancer	7.86e-05	0.0015	CbGeAlD
Dexamethasone—Gastrointestinal disorder—Cisplatin—germ cell cancer	7.85e-05	0.00126	CcSEcCtD
Dexamethasone—Vomiting—Bleomycin—germ cell cancer	7.84e-05	0.00126	CcSEcCtD
Dexamethasone—ANXA1—Class A/1 (Rhodopsin-like receptors)—AVP—germ cell cancer	7.82e-05	0.00236	CbGpPWpGaD
Dexamethasone—SLCO1A2—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	7.8e-05	0.00236	CbGpPWpGaD
Dexamethasone—SLCO1A2—brain—germ cell cancer	7.8e-05	0.00149	CbGeAlD
Dexamethasone—PGR—Signaling by ERBB4—KITLG—germ cell cancer	7.79e-05	0.00236	CbGpPWpGaD
Dexamethasone—Hypotension—Etoposide—germ cell cancer	7.78e-05	0.00125	CcSEcCtD
Dexamethasone—Rash—Bleomycin—germ cell cancer	7.78e-05	0.00125	CcSEcCtD
Dexamethasone—NOS2—Rac1/Pak1/p38/MMP-2 pathway—MYC—germ cell cancer	7.77e-05	0.00235	CbGpPWpGaD
Dexamethasone—Pain—Cisplatin—germ cell cancer	7.77e-05	0.00124	CcSEcCtD
Dexamethasone—Dermatitis—Bleomycin—germ cell cancer	7.77e-05	0.00124	CcSEcCtD
Dexamethasone—NR3C1—midbrain—germ cell cancer	7.76e-05	0.00149	CbGeAlD
Dexamethasone—PTGS2—uterus—germ cell cancer	7.76e-05	0.00148	CbGeAlD
Dexamethasone—SLCO1A2—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	7.68e-05	0.00232	CbGpPWpGaD
Dexamethasone—PTGS2—pituitary gland—germ cell cancer	7.62e-05	0.00146	CbGeAlD
Dexamethasone—CYP2C8—endocrine gland—germ cell cancer	7.61e-05	0.00146	CbGeAlD
Dexamethasone—CYP19A1—brain—germ cell cancer	7.61e-05	0.00146	CbGeAlD
Dexamethasone—NR3C1—bone marrow—germ cell cancer	7.61e-05	0.00146	CbGeAlD
Dexamethasone—Conjunctivitis—Methotrexate—germ cell cancer	7.6e-05	0.00122	CcSEcCtD
Dexamethasone—NR3C1—spinal cord—germ cell cancer	7.57e-05	0.00145	CbGeAlD
Dexamethasone—Asthenia—Ifosfamide—germ cell cancer	7.56e-05	0.00121	CcSEcCtD
Dexamethasone—CYP1A1—female gonad—germ cell cancer	7.56e-05	0.00145	CbGeAlD
Dexamethasone—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—germ cell cancer	7.56e-05	0.00228	CbGpPWpGaD
Dexamethasone—Feeling abnormal—Cisplatin—germ cell cancer	7.49e-05	0.0012	CcSEcCtD
Dexamethasone—Paraesthesia—Etoposide—germ cell cancer	7.48e-05	0.0012	CcSEcCtD
Dexamethasone—Pruritus—Ifosfamide—germ cell cancer	7.46e-05	0.00119	CcSEcCtD
Dexamethasone—CYP2E1—adrenal gland—germ cell cancer	7.39e-05	0.00141	CbGeAlD
Dexamethasone—CYP3A5—female gonad—germ cell cancer	7.39e-05	0.00141	CbGeAlD
Dexamethasone—ABCB1—trigeminal ganglion—germ cell cancer	7.37e-05	0.00141	CbGeAlD
Dexamethasone—NR3C2—Gene Expression—RARS—germ cell cancer	7.36e-05	0.00222	CbGpPWpGaD
Dexamethasone—PTGS2—medulla oblongata—germ cell cancer	7.35e-05	0.00141	CbGeAlD
Dexamethasone—CYP19A1—lymph node—germ cell cancer	7.35e-05	0.00141	CbGeAlD
Dexamethasone—NR3C1—female gonad—germ cell cancer	7.33e-05	0.0014	CbGeAlD
Dexamethasone—Nausea—Bleomycin—germ cell cancer	7.33e-05	0.00117	CcSEcCtD
Dexamethasone—NR3C1—SIDS Susceptibility Pathways—SOX2—germ cell cancer	7.32e-05	0.00221	CbGpPWpGaD
Dexamethasone—Vomiting—Dactinomycin—germ cell cancer	7.31e-05	0.00117	CcSEcCtD
Dexamethasone—CYP2C8—testis—germ cell cancer	7.26e-05	0.00139	CbGeAlD
Dexamethasone—Rash—Dactinomycin—germ cell cancer	7.25e-05	0.00116	CcSEcCtD
Dexamethasone—Decreased appetite—Etoposide—germ cell cancer	7.24e-05	0.00116	CcSEcCtD
Dexamethasone—Diarrhoea—Ifosfamide—germ cell cancer	7.21e-05	0.00115	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Etoposide—germ cell cancer	7.19e-05	0.00115	CcSEcCtD
Dexamethasone—Body temperature increased—Cisplatin—germ cell cancer	7.18e-05	0.00115	CcSEcCtD
Dexamethasone—Fatigue—Etoposide—germ cell cancer	7.18e-05	0.00115	CcSEcCtD
Dexamethasone—Pain—Etoposide—germ cell cancer	7.12e-05	0.00114	CcSEcCtD
Dexamethasone—CYP2E1—spinal cord—germ cell cancer	7.12e-05	0.00136	CbGeAlD
Dexamethasone—ABCB1—embryo—germ cell cancer	7.12e-05	0.00136	CbGeAlD
Dexamethasone—CYP1B1—brain—germ cell cancer	7.11e-05	0.00136	CbGeAlD
Dexamethasone—ABCG2—testis—germ cell cancer	7.06e-05	0.00135	CbGeAlD
Dexamethasone—Haemoglobin—Methotrexate—germ cell cancer	7.05e-05	0.00113	CcSEcCtD
Dexamethasone—CYP1A1—endocrine gland—germ cell cancer	7.03e-05	0.00134	CbGeAlD
Dexamethasone—Haemorrhage—Methotrexate—germ cell cancer	7.02e-05	0.00112	CcSEcCtD
Dexamethasone—ABCC2—lymph node—germ cell cancer	7.02e-05	0.00134	CbGeAlD
Dexamethasone—Dizziness—Ifosfamide—germ cell cancer	6.97e-05	0.00112	CcSEcCtD
Dexamethasone—CYP1A1—head—germ cell cancer	6.94e-05	0.00133	CbGeAlD
Dexamethasone—CYP1B1—lymph node—germ cell cancer	6.87e-05	0.00131	CbGeAlD
Dexamethasone—CYP3A5—endocrine gland—germ cell cancer	6.87e-05	0.00131	CbGeAlD
Dexamethasone—Feeling abnormal—Etoposide—germ cell cancer	6.86e-05	0.0011	CcSEcCtD
Dexamethasone—Nausea—Dactinomycin—germ cell cancer	6.83e-05	0.00109	CcSEcCtD
Dexamethasone—CYP2B6—endocrine gland—germ cell cancer	6.83e-05	0.00131	CbGeAlD
Dexamethasone—NR3C1—endocrine gland—germ cell cancer	6.82e-05	0.0013	CbGeAlD
Dexamethasone—Gastrointestinal pain—Etoposide—germ cell cancer	6.81e-05	0.00109	CcSEcCtD
Dexamethasone—PTGS2—adrenal gland—germ cell cancer	6.81e-05	0.0013	CbGeAlD
Dexamethasone—Visual impairment—Methotrexate—germ cell cancer	6.76e-05	0.00108	CcSEcCtD
Dexamethasone—CYP2C9—endocrine gland—germ cell cancer	6.76e-05	0.00129	CbGeAlD
Dexamethasone—CYP2B6—head—germ cell cancer	6.74e-05	0.00129	CbGeAlD
Dexamethasone—NR3C1—head—germ cell cancer	6.73e-05	0.00129	CbGeAlD
Dexamethasone—PTGS2—midbrain—germ cell cancer	6.72e-05	0.00129	CbGeAlD
Dexamethasone—Vomiting—Ifosfamide—germ cell cancer	6.7e-05	0.00107	CcSEcCtD
Dexamethasone—NR3C1—Generic Transcription Pathway—NR0B1—germ cell cancer	6.68e-05	0.00202	CbGpPWpGaD
Dexamethasone—Rash—Ifosfamide—germ cell cancer	6.65e-05	0.00106	CcSEcCtD
Dexamethasone—Dermatitis—Ifosfamide—germ cell cancer	6.64e-05	0.00106	CcSEcCtD
Dexamethasone—Urticaria—Etoposide—germ cell cancer	6.61e-05	0.00106	CcSEcCtD
Dexamethasone—PTGS2—bone marrow—germ cell cancer	6.58e-05	0.00126	CbGeAlD
Dexamethasone—Abdominal pain—Etoposide—germ cell cancer	6.58e-05	0.00105	CcSEcCtD
Dexamethasone—Body temperature increased—Etoposide—germ cell cancer	6.58e-05	0.00105	CcSEcCtD
Dexamethasone—Eye disorder—Methotrexate—germ cell cancer	6.56e-05	0.00105	CcSEcCtD
Dexamethasone—PTGS2—spinal cord—germ cell cancer	6.55e-05	0.00125	CbGeAlD
Dexamethasone—ANXA1—Spinal Cord Injury—MYC—germ cell cancer	6.55e-05	0.00198	CbGpPWpGaD
Dexamethasone—Asthenia—Cisplatin—germ cell cancer	6.52e-05	0.00104	CcSEcCtD
Dexamethasone—ABCG2—cerebellum—germ cell cancer	6.52e-05	0.00125	CbGeAlD
Dexamethasone—CYP2B6—testis—germ cell cancer	6.51e-05	0.00125	CbGeAlD
Dexamethasone—NR3C1—testis—germ cell cancer	6.5e-05	0.00124	CbGeAlD
Dexamethasone—CYP2E1—endocrine gland—germ cell cancer	6.41e-05	0.00123	CbGeAlD
Dexamethasone—NOS2—Rac1/Pak1/p38/MMP-2 pathway—TP53—germ cell cancer	6.38e-05	0.00193	CbGpPWpGaD
Dexamethasone—Angiopathy—Methotrexate—germ cell cancer	6.37e-05	0.00102	CcSEcCtD
Dexamethasone—PTGS2—female gonad—germ cell cancer	6.35e-05	0.00121	CbGeAlD
Dexamethasone—CYP2E1—head—germ cell cancer	6.33e-05	0.00121	CbGeAlD
Dexamethasone—ABCB1—retina—germ cell cancer	6.29e-05	0.0012	CbGeAlD
Dexamethasone—Nausea—Ifosfamide—germ cell cancer	6.26e-05	0.001	CcSEcCtD
Dexamethasone—Diarrhoea—Cisplatin—germ cell cancer	6.22e-05	0.000995	CcSEcCtD
Dexamethasone—Alopecia—Methotrexate—germ cell cancer	6.2e-05	0.000993	CcSEcCtD
Dexamethasone—CYP2E1—testis—germ cell cancer	6.11e-05	0.00117	CbGeAlD
Dexamethasone—Erythema—Methotrexate—germ cell cancer	6.11e-05	0.000978	CcSEcCtD
Dexamethasone—NOS2—Rac1/Pak1/p38/MMP-2 pathway—HRAS—germ cell cancer	6.11e-05	0.00185	CbGpPWpGaD
Dexamethasone—SLCO1A2—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	6.06e-05	0.00183	CbGpPWpGaD
Dexamethasone—NR3C1—cerebellum—germ cell cancer	6.01e-05	0.00115	CbGeAlD
Dexamethasone—Asthenia—Etoposide—germ cell cancer	5.97e-05	0.000956	CcSEcCtD
Dexamethasone—PTGS2—C-MYB transcription factor network—H2AFZ—germ cell cancer	5.96e-05	0.0018	CbGpPWpGaD
Dexamethasone—ANXA1—GPCR ligand binding—AVP—germ cell cancer	5.95e-05	0.0018	CbGpPWpGaD
Dexamethasone—PTGS2—endocrine gland—germ cell cancer	5.9e-05	0.00113	CbGeAlD
Dexamethasone—Pruritus—Etoposide—germ cell cancer	5.89e-05	0.000943	CcSEcCtD
Dexamethasone—PGR—Validated nuclear estrogen receptor alpha network—MYC—germ cell cancer	5.85e-05	0.00177	CbGpPWpGaD
Dexamethasone—PTGS2—head—germ cell cancer	5.83e-05	0.00111	CbGeAlD
Dexamethasone—PGR—Signaling by ERBB4—FGFR3—germ cell cancer	5.79e-05	0.00175	CbGpPWpGaD
Dexamethasone—ABCB1—telencephalon—germ cell cancer	5.79e-05	0.00111	CbGeAlD
Dexamethasone—Vomiting—Cisplatin—germ cell cancer	5.78e-05	0.000925	CcSEcCtD
Dexamethasone—Rash—Cisplatin—germ cell cancer	5.73e-05	0.000917	CcSEcCtD
Dexamethasone—Dermatitis—Cisplatin—germ cell cancer	5.72e-05	0.000917	CcSEcCtD
Dexamethasone—Diarrhoea—Etoposide—germ cell cancer	5.7e-05	0.000912	CcSEcCtD
Dexamethasone—Ill-defined disorder—Methotrexate—germ cell cancer	5.67e-05	0.000908	CcSEcCtD
Dexamethasone—CYP2E1—cerebellum—germ cell cancer	5.64e-05	0.00108	CbGeAlD
Dexamethasone—PGR—Gene Expression—NR0B1—germ cell cancer	5.56e-05	0.00168	CbGpPWpGaD
Dexamethasone—ABCC2—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	5.51e-05	0.00167	CbGpPWpGaD
Dexamethasone—Malaise—Methotrexate—germ cell cancer	5.51e-05	0.000882	CcSEcCtD
Dexamethasone—Dizziness—Etoposide—germ cell cancer	5.51e-05	0.000881	CcSEcCtD
Dexamethasone—Vertigo—Methotrexate—germ cell cancer	5.49e-05	0.000879	CcSEcCtD
Dexamethasone—PTGS2—C-MYB transcription factor network—KITLG—germ cell cancer	5.49e-05	0.00166	CbGpPWpGaD
Dexamethasone—ABCB1—decidua—germ cell cancer	5.49e-05	0.00105	CbGeAlD
Dexamethasone—CYP2D6—female gonad—germ cell cancer	5.46e-05	0.00104	CbGeAlD
Dexamethasone—CYP2C8—brain—germ cell cancer	5.45e-05	0.00104	CbGeAlD
Dexamethasone—Nausea—Cisplatin—germ cell cancer	5.4e-05	0.000864	CcSEcCtD
Dexamethasone—ANXA1—Spinal Cord Injury—TP53—germ cell cancer	5.38e-05	0.00163	CbGpPWpGaD
Dexamethasone—ANXA1—Integrated Breast Cancer Pathway—MYC—germ cell cancer	5.38e-05	0.00163	CbGpPWpGaD
Dexamethasone—PGR—Signaling by ERBB4—KIT—germ cell cancer	5.32e-05	0.00161	CbGpPWpGaD
Dexamethasone—ABCG2—brain—germ cell cancer	5.3e-05	0.00101	CbGeAlD
Dexamethasone—Convulsion—Methotrexate—germ cell cancer	5.29e-05	0.000848	CcSEcCtD
Dexamethasone—Vomiting—Etoposide—germ cell cancer	5.29e-05	0.000847	CcSEcCtD
Dexamethasone—Rash—Etoposide—germ cell cancer	5.25e-05	0.00084	CcSEcCtD
Dexamethasone—Dermatitis—Etoposide—germ cell cancer	5.24e-05	0.00084	CcSEcCtD
Dexamethasone—Headache—Etoposide—germ cell cancer	5.22e-05	0.000835	CcSEcCtD
Dexamethasone—Myalgia—Methotrexate—germ cell cancer	5.2e-05	0.000833	CcSEcCtD
Dexamethasone—PTGS2—cerebellum—germ cell cancer	5.2e-05	0.000994	CbGeAlD
Dexamethasone—CYP3A4—endocrine gland—germ cell cancer	5.16e-05	0.000987	CbGeAlD
Dexamethasone—Discomfort—Methotrexate—germ cell cancer	5.14e-05	0.000823	CcSEcCtD
Dexamethasone—ABCG2—lymph node—germ cell cancer	5.12e-05	0.000979	CbGeAlD
Dexamethasone—CYP2D6—endocrine gland—germ cell cancer	5.07e-05	0.000971	CbGeAlD
Dexamethasone—CYP1A1—brain—germ cell cancer	5.03e-05	0.000962	CbGeAlD
Dexamethasone—CYP2D6—head—germ cell cancer	5.01e-05	0.000958	CbGeAlD
Dexamethasone—CYP17A1—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	4.99e-05	0.00151	CbGpPWpGaD
Dexamethasone—Anaphylactic shock—Methotrexate—germ cell cancer	4.99e-05	0.000798	CcSEcCtD
Dexamethasone—Infection—Methotrexate—germ cell cancer	4.95e-05	0.000793	CcSEcCtD
Dexamethasone—Nausea—Etoposide—germ cell cancer	4.95e-05	0.000792	CcSEcCtD
Dexamethasone—NOS2—Spinal Cord Injury—MYC—germ cell cancer	4.94e-05	0.00149	CbGpPWpGaD
Dexamethasone—ANXA1—GPCR downstream signaling—OXT—germ cell cancer	4.91e-05	0.00148	CbGpPWpGaD
Dexamethasone—Nervous system disorder—Methotrexate—germ cell cancer	4.89e-05	0.000783	CcSEcCtD
Dexamethasone—CYP2B6—brain—germ cell cancer	4.89e-05	0.000935	CbGeAlD
Dexamethasone—Thrombocytopenia—Methotrexate—germ cell cancer	4.88e-05	0.000782	CcSEcCtD
Dexamethasone—NR3C1—brain—germ cell cancer	4.88e-05	0.000933	CbGeAlD
Dexamethasone—CYP1A1—lymph node—germ cell cancer	4.86e-05	0.000929	CbGeAlD
Dexamethasone—CYP2D6—testis—germ cell cancer	4.84e-05	0.000926	CbGeAlD
Dexamethasone—ABCB1—gonad—germ cell cancer	4.83e-05	0.000924	CbGeAlD
Dexamethasone—PGR—Gene Expression—DNMT3L—germ cell cancer	4.82e-05	0.00146	CbGpPWpGaD
Dexamethasone—Hyperhidrosis—Methotrexate—germ cell cancer	4.82e-05	0.000772	CcSEcCtD
Dexamethasone—CYP1B1—Aryl Hydrocarbon Receptor—MYC—germ cell cancer	4.81e-05	0.00145	CbGpPWpGaD
Dexamethasone—ABCB1—uterus—germ cell cancer	4.8e-05	0.000918	CbGeAlD
Dexamethasone—ABCG2—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	4.8e-05	0.00145	CbGpPWpGaD
Dexamethasone—Anorexia—Methotrexate—germ cell cancer	4.75e-05	0.000761	CcSEcCtD
Dexamethasone—NR3C1—lymph node—germ cell cancer	4.71e-05	0.000902	CbGeAlD
Dexamethasone—ABCB1—pituitary gland—germ cell cancer	4.71e-05	0.000901	CbGeAlD
Dexamethasone—ABCG2—Fluoropyrimidine Activity—TP53—germ cell cancer	4.68e-05	0.00142	CbGpPWpGaD
Dexamethasone—Hypotension—Methotrexate—germ cell cancer	4.66e-05	0.000746	CcSEcCtD
Dexamethasone—PLA2G1B—Metabolism—SLC2A3—germ cell cancer	4.59e-05	0.00139	CbGpPWpGaD
Dexamethasone—CYP2E1—brain—germ cell cancer	4.58e-05	0.000877	CbGeAlD
Dexamethasone—CYP11A1—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	4.57e-05	0.00138	CbGpPWpGaD
Dexamethasone—ABCB1—medulla oblongata—germ cell cancer	4.55e-05	0.00087	CbGeAlD
Dexamethasone—Musculoskeletal discomfort—Methotrexate—germ cell cancer	4.54e-05	0.000727	CcSEcCtD
Dexamethasone—PLA2G1B—Metabolism—SLC22A3—germ cell cancer	4.52e-05	0.00137	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	4.52e-05	0.00137	CbGpPWpGaD
Dexamethasone—Insomnia—Methotrexate—germ cell cancer	4.51e-05	0.000722	CcSEcCtD
Dexamethasone—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CRABP1—germ cell cancer	4.5e-05	0.00136	CbGpPWpGaD
Dexamethasone—PGR—Gene Expression—RARS—germ cell cancer	4.48e-05	0.00135	CbGpPWpGaD
Dexamethasone—Paraesthesia—Methotrexate—germ cell cancer	4.48e-05	0.000717	CcSEcCtD
Dexamethasone—CYP2D6—cerebellum—germ cell cancer	4.47e-05	0.000855	CbGeAlD
Dexamethasone—ANXA1—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	4.46e-05	0.00135	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling by GPCR—OXT—germ cell cancer	4.46e-05	0.00135	CbGpPWpGaD
Dexamethasone—ANXA1—Integrated Breast Cancer Pathway—TP53—germ cell cancer	4.42e-05	0.00134	CbGpPWpGaD
Dexamethasone—Dyspepsia—Methotrexate—germ cell cancer	4.39e-05	0.000703	CcSEcCtD
Dexamethasone—Decreased appetite—Methotrexate—germ cell cancer	4.33e-05	0.000694	CcSEcCtD
Dexamethasone—NR3C1—SIDS Susceptibility Pathways—AVP—germ cell cancer	4.31e-05	0.0013	CbGpPWpGaD
Dexamethasone—Gastrointestinal disorder—Methotrexate—germ cell cancer	4.31e-05	0.000689	CcSEcCtD
Dexamethasone—Fatigue—Methotrexate—germ cell cancer	4.3e-05	0.000688	CcSEcCtD
Dexamethasone—Pain—Methotrexate—germ cell cancer	4.26e-05	0.000683	CcSEcCtD
Dexamethasone—CYP2A6—Fluoropyrimidine Activity—TP53—germ cell cancer	4.26e-05	0.00129	CbGpPWpGaD
Dexamethasone—PTGS2—brain—germ cell cancer	4.22e-05	0.000808	CbGeAlD
Dexamethasone—NOS2—Disease—SLC2A3—germ cell cancer	4.21e-05	0.00127	CbGpPWpGaD
Dexamethasone—ABCB1—adrenal gland—germ cell cancer	4.21e-05	0.000805	CbGeAlD
Dexamethasone—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—germ cell cancer	4.16e-05	0.00126	CbGpPWpGaD
Dexamethasone—ABCB1—midbrain—germ cell cancer	4.16e-05	0.000795	CbGeAlD
Dexamethasone—Feeling abnormal—Methotrexate—germ cell cancer	4.11e-05	0.000658	CcSEcCtD
Dexamethasone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—germ cell cancer	4.08e-05	0.00123	CbGpPWpGaD
Dexamethasone—PTGS2—lymph node—germ cell cancer	4.08e-05	0.00078	CbGeAlD
Dexamethasone—Gastrointestinal pain—Methotrexate—germ cell cancer	4.08e-05	0.000653	CcSEcCtD
Dexamethasone—ABCB1—bone marrow—germ cell cancer	4.07e-05	0.000779	CbGeAlD
Dexamethasone—NOS2—Spinal Cord Injury—TP53—germ cell cancer	4.06e-05	0.00123	CbGpPWpGaD
Dexamethasone—ABCB1—spinal cord—germ cell cancer	4.05e-05	0.000776	CbGeAlD
Dexamethasone—ABCB11—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	4.01e-05	0.00121	CbGpPWpGaD
Dexamethasone—SLCO1A2—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	3.96e-05	0.0012	CbGpPWpGaD
Dexamethasone—Urticaria—Methotrexate—germ cell cancer	3.96e-05	0.000634	CcSEcCtD
Dexamethasone—Abdominal pain—Methotrexate—germ cell cancer	3.94e-05	0.000631	CcSEcCtD
Dexamethasone—Body temperature increased—Methotrexate—germ cell cancer	3.94e-05	0.000631	CcSEcCtD
Dexamethasone—ABCB1—female gonad—germ cell cancer	3.92e-05	0.000751	CbGeAlD
Dexamethasone—SLCO1A2—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	3.9e-05	0.00118	CbGpPWpGaD
Dexamethasone—CYP1B1—Aryl Hydrocarbon Receptor—HRAS—germ cell cancer	3.77e-05	0.00114	CbGpPWpGaD
Dexamethasone—PTGS2—C-MYB transcription factor network—KIT—germ cell cancer	3.74e-05	0.00113	CbGpPWpGaD
Dexamethasone—PLA2G1B—Metabolism—CRABP1—germ cell cancer	3.69e-05	0.00111	CbGpPWpGaD
Dexamethasone—ANXA1—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	3.66e-05	0.00111	CbGpPWpGaD
Dexamethasone—ABCB1—endocrine gland—germ cell cancer	3.65e-05	0.000698	CbGeAlD
Dexamethasone—CYP2D6—brain—germ cell cancer	3.63e-05	0.000695	CbGeAlD
Dexamethasone—NR0B1—Gene Expression—H2AFZ—germ cell cancer	3.63e-05	0.0011	CbGpPWpGaD
Dexamethasone—CYP3A43—Metabolism—SLC2A3—germ cell cancer	3.62e-05	0.00109	CbGpPWpGaD
Dexamethasone—ABCC2—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	3.61e-05	0.00109	CbGpPWpGaD
Dexamethasone—ABCB1—head—germ cell cancer	3.6e-05	0.000689	CbGeAlD
Dexamethasone—SLCO1A2—SLC-mediated transmembrane transport—AVP—germ cell cancer	3.6e-05	0.00109	CbGpPWpGaD
Dexamethasone—Asthenia—Methotrexate—germ cell cancer	3.58e-05	0.000573	CcSEcCtD
Dexamethasone—CYP3A43—Metabolism—SLC22A3—germ cell cancer	3.56e-05	0.00108	CbGpPWpGaD
Dexamethasone—ABCC2—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	3.55e-05	0.00107	CbGpPWpGaD
Dexamethasone—Pruritus—Methotrexate—germ cell cancer	3.53e-05	0.000565	CcSEcCtD
Dexamethasone—ABCB1—testis—germ cell cancer	3.48e-05	0.000666	CbGeAlD
Dexamethasone—Diarrhoea—Methotrexate—germ cell cancer	3.41e-05	0.000546	CcSEcCtD
Dexamethasone—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—germ cell cancer	3.41e-05	0.00103	CbGpPWpGaD
Dexamethasone—ANXA1—GPCR downstream signaling—AVP—germ cell cancer	3.36e-05	0.00102	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	3.35e-05	0.00101	CbGpPWpGaD
Dexamethasone—PTGS2—Aryl Hydrocarbon Receptor—MYC—germ cell cancer	3.34e-05	0.00101	CbGpPWpGaD
Dexamethasone—Dizziness—Methotrexate—germ cell cancer	3.3e-05	0.000528	CcSEcCtD
Dexamethasone—ABCB1—cerebellum—germ cell cancer	3.22e-05	0.000615	CbGeAlD
Dexamethasone—NR3C1—Gene Expression—NR0B1—germ cell cancer	3.21e-05	0.000972	CbGpPWpGaD
Dexamethasone—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—germ cell cancer	3.19e-05	0.000963	CbGpPWpGaD
Dexamethasone—Vomiting—Methotrexate—germ cell cancer	3.17e-05	0.000508	CcSEcCtD
Dexamethasone—NR3C1—AP-1 transcription factor network—MYC—germ cell cancer	3.15e-05	0.000951	CbGpPWpGaD
Dexamethasone—Rash—Methotrexate—germ cell cancer	3.14e-05	0.000503	CcSEcCtD
Dexamethasone—Dermatitis—Methotrexate—germ cell cancer	3.14e-05	0.000503	CcSEcCtD
Dexamethasone—ABCG2—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	3.14e-05	0.000948	CbGpPWpGaD
Dexamethasone—Headache—Methotrexate—germ cell cancer	3.12e-05	0.0005	CcSEcCtD
Dexamethasone—ABCG2—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	3.09e-05	0.000934	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling by GPCR—AVP—germ cell cancer	3.05e-05	0.000923	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	3.02e-05	0.000914	CbGpPWpGaD
Dexamethasone—Nausea—Methotrexate—germ cell cancer	2.96e-05	0.000474	CcSEcCtD
Dexamethasone—CYP1A1—Aryl Hydrocarbon Receptor—MYC—germ cell cancer	2.96e-05	0.000895	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	2.91e-05	0.00088	CbGpPWpGaD
Dexamethasone—CYP3A43—Metabolism—CRABP1—germ cell cancer	2.9e-05	0.000878	CbGpPWpGaD
Dexamethasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—germ cell cancer	2.8e-05	0.000846	CbGpPWpGaD
Dexamethasone—NR3C1—Gene Expression—DNMT3L—germ cell cancer	2.79e-05	0.000842	CbGpPWpGaD
Dexamethasone—NR3C2—Gene Expression—H2AFZ—germ cell cancer	2.77e-05	0.000838	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism—SLC2A3—germ cell cancer	2.77e-05	0.000837	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism—SLC22A3—germ cell cancer	2.73e-05	0.000824	CbGpPWpGaD
Dexamethasone—NOS2—Circadian rythm related genes—TP53—germ cell cancer	2.65e-05	0.000801	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—OXT—germ cell cancer	2.63e-05	0.000796	CbGpPWpGaD
Dexamethasone—PTGS2—Aryl Hydrocarbon Receptor—HRAS—germ cell cancer	2.62e-05	0.000792	CbGpPWpGaD
Dexamethasone—ABCB1—brain—germ cell cancer	2.61e-05	0.0005	CbGeAlD
Dexamethasone—NR0B1—Generic Transcription Pathway—MYC—germ cell cancer	2.6e-05	0.000787	CbGpPWpGaD
Dexamethasone—ABCB1—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	2.59e-05	0.000784	CbGpPWpGaD
Dexamethasone—NR3C1—Gene Expression—RARS—germ cell cancer	2.59e-05	0.000783	CbGpPWpGaD
Dexamethasone—NR3C1—AP-1 transcription factor network—TP53—germ cell cancer	2.58e-05	0.000781	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—SLC2A3—germ cell cancer	2.53e-05	0.000765	CbGpPWpGaD
Dexamethasone—ABCB1—lymph node—germ cell cancer	2.52e-05	0.000483	CbGeAlD
Dexamethasone—CYP4A11—Metabolism—SLC2A3—germ cell cancer	2.51e-05	0.000758	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—SLC22A3—germ cell cancer	2.49e-05	0.000754	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—SLC22A3—germ cell cancer	2.47e-05	0.000746	CbGpPWpGaD
Dexamethasone—NOS2—Disease—FGF4—germ cell cancer	2.42e-05	0.000732	CbGpPWpGaD
Dexamethasone—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—germ cell cancer	2.32e-05	0.000703	CbGpPWpGaD
Dexamethasone—PGR—Signaling by ERBB4—HRAS—germ cell cancer	2.3e-05	0.000695	CbGpPWpGaD
Dexamethasone—NR3C1—Glucocorticoid receptor regulatory network—TP53—germ cell cancer	2.28e-05	0.000688	CbGpPWpGaD
Dexamethasone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—germ cell cancer	2.25e-05	0.000679	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—FGF4—germ cell cancer	2.25e-05	0.000679	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—SLC2A3—germ cell cancer	2.22e-05	0.000672	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism—CRABP1—germ cell cancer	2.22e-05	0.000672	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—SLC22A3—germ cell cancer	2.19e-05	0.000662	CbGpPWpGaD
Dexamethasone—NOS2—Disease—H2AFZ—germ cell cancer	2.16e-05	0.000653	CbGpPWpGaD
Dexamethasone—PTGS2—C-MYB transcription factor network—MYC—germ cell cancer	2.06e-05	0.000623	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—CRABP1—germ cell cancer	2.03e-05	0.000615	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	2.02e-05	0.000611	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—CRABP1—germ cell cancer	2.01e-05	0.000608	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—H2AFZ—germ cell cancer	2.01e-05	0.000607	CbGpPWpGaD
Dexamethasone—NOS2—Disease—KITLG—germ cell cancer	1.99e-05	0.000601	CbGpPWpGaD
Dexamethasone—NR3C2—Generic Transcription Pathway—MYC—germ cell cancer	1.99e-05	0.000601	CbGpPWpGaD
Dexamethasone—CYP19A1—Integrated Breast Cancer Pathway—MYC—germ cell cancer	1.93e-05	0.000583	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—SLC2A3—germ cell cancer	1.86e-05	0.000561	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—KITLG—germ cell cancer	1.85e-05	0.000558	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—SLC22A3—germ cell cancer	1.83e-05	0.000553	CbGpPWpGaD
Dexamethasone—SLCO1A2—Transmembrane transport of small molecules—AVP—germ cell cancer	1.83e-05	0.000552	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—AVP—germ cell cancer	1.8e-05	0.000545	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	1.79e-05	0.000542	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—CRABP1—germ cell cancer	1.79e-05	0.00054	CbGpPWpGaD
Dexamethasone—ABCB1—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	1.7e-05	0.000513	CbGpPWpGaD
Dexamethasone—PGR—Gene Expression—H2AFZ—germ cell cancer	1.69e-05	0.00051	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—SLC2A3—germ cell cancer	1.68e-05	0.000507	CbGpPWpGaD
Dexamethasone—ABCB1—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	1.67e-05	0.000505	CbGpPWpGaD
Dexamethasone—ABCC2—Transmembrane transport of small molecules—AVP—germ cell cancer	1.66e-05	0.000503	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—SLC22A3—germ cell cancer	1.65e-05	0.000499	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	1.64e-05	0.000497	CbGpPWpGaD
Dexamethasone—PTGS2—C-MYB transcription factor network—HRAS—germ cell cancer	1.62e-05	0.000489	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—SLC2A3—germ cell cancer	1.62e-05	0.000488	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—SLC22A3—germ cell cancer	1.59e-05	0.000481	CbGpPWpGaD
Dexamethasone—CYP19A1—Integrated Breast Cancer Pathway—TP53—germ cell cancer	1.58e-05	0.000479	CbGpPWpGaD
Dexamethasone—PTGS2—Spinal Cord Injury—MYC—germ cell cancer	1.57e-05	0.000474	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—CRABP1—germ cell cancer	1.49e-05	0.00045	CbGpPWpGaD
Dexamethasone—NOS2—Disease—FGFR3—germ cell cancer	1.48e-05	0.000447	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—SLC2A3—germ cell cancer	1.47e-05	0.000444	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	1.47e-05	0.000444	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—SLC2A3—germ cell cancer	1.46e-05	0.00044	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—SLC22A3—germ cell cancer	1.45e-05	0.000437	CbGpPWpGaD
Dexamethasone—ABCG2—Transmembrane transport of small molecules—AVP—germ cell cancer	1.45e-05	0.000437	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—OXT—germ cell cancer	1.44e-05	0.000435	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—SLC22A3—germ cell cancer	1.43e-05	0.000434	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—FGFR3—germ cell cancer	1.37e-05	0.000415	CbGpPWpGaD
Dexamethasone—NOS2—Disease—KIT—germ cell cancer	1.36e-05	0.00041	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—CRABP1—germ cell cancer	1.35e-05	0.000407	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—SLC2A3—germ cell cancer	1.34e-05	0.000404	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	1.34e-05	0.000404	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—SLC2A3—germ cell cancer	1.34e-05	0.000404	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—SLC22A3—germ cell cancer	1.32e-05	0.000397	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—CRABP1—germ cell cancer	1.3e-05	0.000392	CbGpPWpGaD
Dexamethasone—PTGS2—Spinal Cord Injury—TP53—germ cell cancer	1.29e-05	0.00039	CbGpPWpGaD
Dexamethasone—NOS2—Hemostasis—TP53—germ cell cancer	1.27e-05	0.000383	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—KIT—germ cell cancer	1.26e-05	0.000381	CbGpPWpGaD
Dexamethasone—NR0B1—Gene Expression—MYC—germ cell cancer	1.25e-05	0.000379	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—FGF4—germ cell cancer	1.23e-05	0.000371	CbGpPWpGaD
Dexamethasone—NOS2—Hemostasis—HRAS—germ cell cancer	1.21e-05	0.000366	CbGpPWpGaD
Dexamethasone—PGR—Generic Transcription Pathway—MYC—germ cell cancer	1.21e-05	0.000366	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—CRABP1—germ cell cancer	1.18e-05	0.000357	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—CRABP1—germ cell cancer	1.17e-05	0.000354	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—SLC2A3—germ cell cancer	1.12e-05	0.000339	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—SLC22A3—germ cell cancer	1.1e-05	0.000334	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—H2AFZ—germ cell cancer	1.1e-05	0.000332	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—SLC2A3—germ cell cancer	1.08e-05	0.000326	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—CRABP1—germ cell cancer	1.07e-05	0.000324	CbGpPWpGaD
Dexamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	1.07e-05	0.000323	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—SLC22A3—germ cell cancer	1.06e-05	0.000321	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—SLC2A3—germ cell cancer	1.06e-05	0.000319	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—SLC2A3—germ cell cancer	1.05e-05	0.000318	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—SLC22A3—germ cell cancer	1.04e-05	0.000314	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—SLC22A3—germ cell cancer	1.04e-05	0.000313	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—KITLG—germ cell cancer	1.01e-05	0.000305	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—SLC2A3—germ cell cancer	9.95e-06	0.000301	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—AVP—germ cell cancer	9.87e-06	0.000298	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—SLC22A3—germ cell cancer	9.8e-06	0.000296	CbGpPWpGaD
Dexamethasone—NR3C1—Gene Expression—H2AFZ—germ cell cancer	9.76e-06	0.000295	CbGpPWpGaD
Dexamethasone—NR3C2—Gene Expression—MYC—germ cell cancer	9.57e-06	0.000289	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling by GPCR—HRAS—germ cell cancer	9.22e-06	0.000279	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—SLC2A3—germ cell cancer	9.12e-06	0.000276	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—CRABP1—germ cell cancer	9e-06	0.000272	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—SLC22A3—germ cell cancer	8.98e-06	0.000272	CbGpPWpGaD
Dexamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	8.77e-06	0.000265	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—CRABP1—germ cell cancer	8.65e-06	0.000261	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—CRABP1—germ cell cancer	8.47e-06	0.000256	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—CRABP1—germ cell cancer	8.45e-06	0.000256	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—SLC2A3—germ cell cancer	8.14e-06	0.000246	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—SLC22A3—germ cell cancer	8.02e-06	0.000242	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—CRABP1—germ cell cancer	7.99e-06	0.000241	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—SLC2A3—germ cell cancer	7.95e-06	0.00024	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—SLC22A3—germ cell cancer	7.83e-06	0.000237	CbGpPWpGaD
Dexamethasone—ABCB1—Transmembrane transport of small molecules—AVP—germ cell cancer	7.82e-06	0.000236	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—FGF4—germ cell cancer	7.69e-06	0.000232	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	7.57e-06	0.000229	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—FGFR3—germ cell cancer	7.5e-06	0.000227	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—SLC2A3—germ cell cancer	7.49e-06	0.000226	CbGpPWpGaD
Dexamethasone—NOS2—Disease—MYC—germ cell cancer	7.47e-06	0.000226	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—SLC2A3—germ cell cancer	7.42e-06	0.000224	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—SLC22A3—germ cell cancer	7.37e-06	0.000223	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—CRABP1—germ cell cancer	7.32e-06	0.000221	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—SLC22A3—germ cell cancer	7.31e-06	0.000221	CbGpPWpGaD
Dexamethasone—NR3C1—Generic Transcription Pathway—MYC—germ cell cancer	7e-06	0.000212	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—MYC—germ cell cancer	6.93e-06	0.00021	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—KIT—germ cell cancer	6.89e-06	0.000208	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—H2AFZ—germ cell cancer	6.86e-06	0.000207	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—CRABP1—germ cell cancer	6.54e-06	0.000198	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—CRABP1—germ cell cancer	6.38e-06	0.000193	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—KITLG—germ cell cancer	6.32e-06	0.000191	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	6.22e-06	0.000188	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—CRABP1—germ cell cancer	6.01e-06	0.000182	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—CRABP1—germ cell cancer	5.96e-06	0.00018	CbGpPWpGaD
Dexamethasone—NOS2—Disease—HRAS—germ cell cancer	5.86e-06	0.000177	CbGpPWpGaD
Dexamethasone—PGR—Gene Expression—MYC—germ cell cancer	5.83e-06	0.000176	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—TP53—germ cell cancer	5.69e-06	0.000172	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—HRAS—germ cell cancer	5.44e-06	0.000165	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—SLC2A3—germ cell cancer	4.9e-06	0.000148	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—SLC22A3—germ cell cancer	4.82e-06	0.000146	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—FGFR3—germ cell cancer	4.69e-06	0.000142	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—KIT—germ cell cancer	4.31e-06	0.00013	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—CRABP1—germ cell cancer	3.93e-06	0.000119	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—MYC—germ cell cancer	3.79e-06	0.000115	CbGpPWpGaD
Dexamethasone—NR3C1—Gene Expression—MYC—germ cell cancer	3.37e-06	0.000102	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—TP53—germ cell cancer	3.11e-06	9.41e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—HRAS—germ cell cancer	2.98e-06	9e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—MYC—germ cell cancer	2.37e-06	7.17e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—HRAS—germ cell cancer	1.86e-06	5.63e-05	CbGpPWpGaD
